Preferred Label : ganirelix;
MeSH synonym : LHRH, N-acetyl-2-naphthylalanyl(1)-(4-chlorophenylalanyl)(2)-3-pyrdinylalanyl(3)-diethylhomoarginyl(6,8)-alaninamide(10)-; LHRH,N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Et2-hArg(6,8)-AlaNH2(10)-; N-Ac-(2-naphthyl)Ala-2-(4-Cl-Phe)-3-(3-pyridinyl-Ala)-6,8-Et2-hArg-10-AlaNH2-LHRH; GnRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Et2-hArg(6,8)-AlaNH2(10)-;
MeSH hyponym : N-acetyl-3-(2-naphthyl)-D-alanyl-p-chloro-D-phenylalanyl-3-(3-pyridyl)-D-alanyl-L-seryl-L-tyrosyl-N(sup
6)-(N,N'-diethylamidino)-D-lysyl-L-leucyl-N(sup 6)-(N,N'-diethylamidino)-L-lysyl-L-prolyl-D-alaninamide
diacetate (salt); ganirelix diacetate; RS-26306;
MeSH CAS label : D-Alaninamide, N-acetyl-3-(1-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-L-tyrosyl-N6-(bis(ethylamino)methylene)-D-lysyl-L-leucyl-N6-(bis(ethylamino)methylene)-L-lysyl-L-prolyl-;
MeSH Related Number : ganirelix diacetate; 129311-55-3 (diacetate); 123246-29-7; 124904-93-4; 56U7906FQW;
Registry Number MeSH : 123246-29-7;
Related CAS MeSH : 129311-55-3 (ganirelix diacetate);
related registry number list (CISMeF) : 129311-55-3 (diacetate);
Is substance : O;
UNII : IX503L9WN0;
Origin ID : C061018;
UMLS CUI : C0073629;
ATC code(s)
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
- ganirelix [International Nonproprietary Name]
Exact mapping(s) to DCI
- ganirelix [International Nonproprietary Name]
MeSH indexing information
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
- ganirelix [International Nonproprietary Name]
https://www.ema.europa.eu/en/medicines/human/EPAR/ganirelix-gedeon-richter
2022
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drugs, generic
ganirelix
hormone antagonists
ganirelix
ganirelix
---
https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/cetrotide-3788.html
2016
false
Canada
French
English
evaluation of the transparency committee
ganirelix
gonadotropin-releasing hormone
hormone antagonists
ganirelix
cetrorelix
cetrorelix
hormone antagonists
cetrorelix
ganirelix
drug costs
treatment outcome
reproductive techniques, assisted
injections, subcutaneous
drug information
---
http://www.has-sante.fr/portail/jcms/c_1260370/orgalutran
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-06/orgalutran_06_06_2012_avis_ct10704.pdf
http://www.has-sante.fr/portail/jcms/c_493313/orgalutran
http://www.has-sante.fr/portail/jcms/c_398919/orgalutran-0-25-mg/0-5-ml-solution-injectable-en-seringue-pre-remplie-boite-de-1-et-boite-de-5
2012
France
French
evaluation of the transparency committee
gonadotropin-releasing hormone
ganirelix
ganirelix
hormone antagonists
gonadotropin-releasing hormone
insurance, health, reimbursement
reproductive techniques, assisted
ovarian hyperstimulation syndrome
luteinizing hormone
---
https://www.ema.europa.eu/medicines/human/EPAR/Orgalutran
2011
United Kingdom
French
English
syndication feed
Contraindications, Procedure
hormone antagonists
hormone antagonists
hormone antagonists
hormone antagonists
treatment outcome
drug evaluation
infertility, female
ganirelix
gonadotropin-releasing hormone
ganirelix
ganirelix
gonadotropin-releasing hormone
package leaflet
drug evaluation
summary of product characteristics
Contraindications, Drug
---
http://www.meddispar.fr/medicaments/3553018
2008
France
French
injections, subcutaneous
drug prescriptions
legislation, drug
ganirelix
gonadotropin-releasing hormone
hormone antagonists
ganirelix
gonadotropin-releasing hormone
drug information
---
http://www.meddispar.fr/medicaments/3553024
2008
France
French
gonadotropin-releasing hormone
injections, subcutaneous
drug prescriptions
legislation, drug
self administration
ganirelix
hormone antagonists
gonadorelin
gonadotropin-releasing hormone
drug information
---